Comparative Cost Effectiveness of Varicella, Hepatitis A, and Pneumococcal Conjugate Vaccines
- 1 December 2001
- journal article
- research article
- Published by Elsevier in Preventive Medicine
- Vol. 33 (6) , 639-645
- https://doi.org/10.1006/pmed.2001.0938
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease RatesArchives of Pediatrics & Adolescent Medicine, 2000
- Varicella Mortality: Trends before Vaccine Licensure in the United States, 1970–1994The Journal of Infectious Diseases, 2000
- Cost-effectiveness of Pneumococcal VaccineJAMA, 2000
- Cost-utility analyses of clinical preventive services11The full text of this article is available via AJPM Online at http://www.elsevier.com/locate/ajpmonline.American Journal of Preventive Medicine, 2000
- COSTS OF OTITIS MEDIA IN A MANAGED CARE POPULATIONThe Pediatric Infectious Disease Journal, 2000
- Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young ChildrenJAMA, 2000
- The cost of hepatitis A infections in American adolescents and adults in 1997Hepatology, 2000
- An ounce of prevention … what are the returns?: Second edition, 1999American Journal of Preventive Medicine, 1999
- Recommendations for Reporting Cost-effectiveness AnalysesJAMA, 1996
- Childhood vaccination against chickenpox: An analysis of benefits and costsThe Journal of Pediatrics, 1994